Exchange: NASDAQ·Updated 12:32 PM EDT

VCRE Vicore Pharma Holding AB - ADR

$11.24
$0.1688
(1.52%)
Today
EarningsNov 5
Vol17,554.00

About VCRE

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
49

Neutral Sentiment

How do you feel about VCRE?

Advertisement|Remove ads.